Feasibility Study of the FARAFLEX Mapping and PFA System — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Feasibility Study of the FARAFLEX Mapping and PFA System — Stella

Recruiting

Back to Atrial Fibrillation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(4 sites)

Belgium

UZ Brussel Hospital, Brussels

Croatia

Klinicki bolnicki centar Split, Split

Czechia

Nemocnice Na Homolce Hospital, Prague

Italy

Fondazione PTV - Policlinico Tor Vergata, Roma

Key details

Sponsor

Boston Scientific Corporation

Enrollment target

~250 participants

Started

February 2025

Primary completion

February 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov